Health Care Counsel Blog
887 total results. Page 20 of 36.
The health care industry continues to be a top priority of the Justice Department with respect to False Claims Act enforcement. In the meantime, investment in a robust compliance program may pay off in cooperation credits to mitigate a False Claims violation.
The Oregon Department of Consumer and Business Services (the Department) issued a proposed bulletin on January 26 that seeks to provide guidance to drug manufacturers regarding the Department’s interpretation of what constitutes a “new prescription drug” for purposes of price reporting.
Headlines that Matter for Companies and Executives in Regulated Industries
The federal government revealed in a recent report that of the $3 billion it recovered last year from companies charged with fraud and abuse, more than $2.6 billion involved the health care industry, marking the tenth consecutive year that the Department of Justice recovered more than $2 billion fro
Headlines that Matter for Companies and Executives in Regulated Industries
Headlines that Matter for Companies and Executives in Regulated Industries
Health Care Co-Leader Stephanie Trunk will present at CBI’s Medicaid and Government Pricing Congress.
In welcome news to most anyone who supervises, employs, credentials, or is a physician assistant, amendments to California Business and Professions Code Section 3500 et seq., effective January 1, 2020, significantly simplify the supervision requirements for PAs in California.
Headlines that Matter for Companies and Executives in Regulated Industries
Headlines that Matter for Companies and Executives in Regulated Industries
Natarajan addressed an important question: When may physicians who are the subject of a peer review hearing challenge the hearing officer in their cases on the ground that the hearing officer is biased?
Headlines that Matter for Companies and Executives in Regulated Industries
The California Court of Appeal gave licensees of health care facilities good news by expanding the scope of the “reasonable licensee” defense when the California Department of Public Health (CDPH) issues a citation and imposes penalties.
In what is widely considered to signal intensified focus by the Federal government on Medicaid supplemental payments and related State Medicaid financing mechanisms, the CMS on November 18, 2019 proposed the Medicaid Financing and Accountability Regulation.
Headlines that Matter for Companies and Executives in Regulated Industries
CMS issued an Interim Final Rule with comment period that further delays the inclusion of the US territories in the definitions of “States” and “United States” for purposes of the Medicaid Drug Rebate Program from April 1, 2020 until April 1, 2022.
Headlines that Matter for Companies and Executives in Regulated Industries
Headlines that Matter for Companies and Executives in Regulated Industries
Headlines that Matter for Companies and Executives in Regulated Industries
Governor Newsom signed AB 51, codified as Labor Code section 432.6, which prohibits California employers from requiring an employee to sign an arbitration agreement “as a condition of employment, continued employment, or the receipt of any employment-related benefit.”
Headlines that Matter for Companies and Executives in Regulated Industries
In a decision very favorable to California hospitals and medical staffs, the Court of Appeal rejected a physician’s argument that he was denied due process during his peer review hearing because of hearing officer alleged bias.
The Federal Trade Commission issued a decision last week illustrating that even sophisticated executives need reminding that emails and texts will be “Exhibit A” of an antitrust violation.
Headlines that Matter for Companies and Executives in Regulated Industries
With the news media covering the link between marijuana vaping, deaths, and lung conditions, California’s push to add THC to the Proposition 65 harmful chemicals list could mean financial, legal, and reputational challenges for cannabis businesses.